| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.08 |